Try GOLD - Free
Sun Pharma Net Profit Falls on US Antitrust Settlement
Mint Hyderabad
|August 01, 2025
Sun Pharmaceutical Industries Ltd.'s revenue from operations for the April-June period beat Street expectations, rising 9.4% year-on-year to ₹13,851 crore. However, the drugmaker's net profit fell due to exceptional items, including settlement costs in a pricing antitrust litigation in the US and the discontinuation of clinical studies on one of its drugs.
The company posted a net profit of ₹2,279 crore in Q1FY26, down 20% from a year earlier.
Healthy double-digit growth in its India business and innovative medicines pipeline boosted its revenue and EBITDA margins during the quarter. The drugmaker has been banking on both segments to drive growth in FY26.
This story is from the August 01, 2025 edition of Mint Hyderabad.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 10,000+ magazines and newspapers.
Already a subscriber? Sign In
MORE STORIES FROM Mint Hyderabad
Mint Hyderabad
Opt for broad-based market indices over passive investing themes’
How can investors select simple and suitable passive funds for their portfolios?
3 mins
February 27, 2026
Mint Hyderabad
In a first, U.S. deploys combat jets to Israel for potential wartime mission in Iran
The U.S. has sent top-of-the-line fighters to Israel, marking the first time it has deployed combat aircraft to the country for a potential wartime mission as the two nations prepare to square off against Iran.
3 mins
February 27, 2026
Mint Hyderabad
Clear pathways for turnaround artists to rescue firms in distress
Specialists would be readier to take on the challenge if doing so did not entail significant legal risks
3 mins
February 27, 2026
Mint Hyderabad
Banking: Has the credit-deposit ratio lost its relevance?
Is there an ideal credit-deposit (CD) ratio for the banking system or is the concept passé?
4 mins
February 27, 2026
Mint Hyderabad
No relief for Jindal Poly in class action
na setback for Jindal Poly Films, the National Company Law Appellate Tribu- nal (NCLAT) on Thursday refused to stay proceedings in India’s first corporate class action suit, filed by minority shareholders alleging fraudulent conduct and the siphoning of over ₹2,500 crore by the firm’s promoters and management.
2 mins
February 27, 2026
Mint Hyderabad
Frequent school bomb threats hold a mirror to society
n the past few days, nearly every alternate day has brought news of bomb-threat emails sent to one or more schools in Delhi.
3 mins
February 27, 2026
Mint Hyderabad
India-Israel ties a 'special strategic partnership' now
The countries have also agreed to fast-track a long-awaited bilateral free trade agreement
1 mins
February 27, 2026
Mint Hyderabad
Crocs bets on India as its top 6 global mkt, targets Gen-Z
Once dismissed as an “ugly” shoe, Crocs is now betting big on India.
1 mins
February 27, 2026
Mint Hyderabad
Follow the Outlander trail across Scotland
I found Outlander by chance one evening when channel-surfing turned into staying put.
3 mins
February 27, 2026
Mint Hyderabad
How Waaree Energies may sidestep new US solar duties
Becoming whole
1 mins
February 27, 2026
Listen
Translate
Change font size

